Briefing: US existing home sales unexpectedly increase in February
Strategic angle: A surprising rise in existing home sales offers a glimmer of hope for the housing market.
Briefing: 'Self-defeating': EU and US clash over Russia sanctions relief as prices soar
Strategic angle: Granting sanctions relief to Russia would be 'self-defeating', Commissioner Valdis Dombrovskis said after Donald Trump's announcement.
Briefing: US homes sales bounced back in February as homebuyers seized on easing mortgage rates
Strategic angle: Homebuyers are responding positively to lower mortgage rates, leading to a rebound in US home sales.
Briefing: Federal appeals court orders end to SAVE plan used by millions of student loan borrowers
Strategic angle: A federal appeals court has ruled to terminate the SAVE plan, impacting millions of student loan borrowers.
Briefing: The Trump administration’s push for nuclear power
Strategic angle: Exploring the implications of the Trump administration's advocacy for nuclear energy.
Briefing: V-bucks are getting more X-pensive
Strategic angle: Fortnite's in-game currency will be reduced in quantity while prices remain the same starting March 19th.
Briefing: The twist in the Ticketmaster antitrust fight
Strategic angle: A lot of people are mad at Ticketmaster, and have been for a long time. The US government's case against Live Nation-Ticketmaster appears poised to lay bare some of the strangeness.
Briefing: Living craft traditions flourish in workshops, house museums and restored heritage spaces
Strategic angle: Traditional craftsmanship continues to evolve through artisan studios, intimate house museums and revitalised cultural spaces, where heritage techniques intersect with modern design and inspire a new generation of makers.
Briefing: February home sales see small rebound, but supply growth is 'sluggish'
Strategic angle: Home sales made a small gain to start the year, but higher mortgage rates now could throw cold water on the spring season.
Trump says Iran 'war is very complete,' talks to Putin: Reports
U.S. stock market indices rose on the heels of reported comments by President Donald Trump that the war against Iran could be over sooner than first expected.
Briefing: U.S. Senator Probes FDA Amid BioNTech Founders' Departure
Strategic angle: The co-founders of BioNTech, known for their Covid-19 vaccine, are set to leave the company to launch a new mRNA-focused venture.
Briefing: Joey Barton charged after assault near golf club
Strategic angle: The former footballer is arrested along with a second suspect near Huyton and Prescot Golf Club.
Briefing: Audi's New RS3 Honors The Legendary Five-Cylinder Engine
Strategic angle: With a coilover suspension and lots of carbon fiber, the RS3 Competition Limited might be Audi's five-cylinder sendoff.
Briefing: Volkswagen Group profits take big hit on Porsche shift
Strategic angle: Strategic readjustment at Porsche and declining sales in key markets impact VW's profits significantly.
Briefing: Long lines form at US airports as DHS shutdown slows security checks
Strategic angle: Travelers faced hours-long waits at security checkpoints at airports in Houston and New Orleans due to a partial shutdown of the US Department of Homeland Security.
Briefing: Trump reiterates threat of a 'friendly takeover' of Cuba as fuel crisis deepens
Strategic angle: The comments come less than a week after Trump suggested that his administration would turn its sights on Havana.
Briefing: Identity theft can cost you during tax season: It's 'a terrible reverse lottery,' one victim says
Strategic angle: Employment-related identity theft is on the rise. Victims may not find out until tax season.
Briefing: Investors’ Confidence Boosted Perimeter Solutions (PRM) in Q4
Strategic angle: Investors’ confidence has positively impacted Perimeter Solutions (PRM) in the fourth quarter.
Briefing: Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Strategic angle: An analysis of CRISPR Therapeutics' potential in the market.
Briefing: Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)
Strategic angle: Wedbush maintains a positive outlook on Tango Therapeutics, signaling confidence in its performance.